Pulmonary Drug Delivery System

Aerosol therapy is a foundational procedure for the treatment of pulmonary conditions, including COVID-19. However, the risk for increased transmission when delivering aerosolized medications to patients with COVID-19 is a real concern for healthcare professionals. Various nebulizers, or aerosol-delivery devices exist, and quantity of medication delivered, aerosol particle size, and treatment time are important factors in evaluating the performance of these devices.3 The Circulaire® II Pulmonary Drug Delivery System is an FDA approved device that uses the conserver principle through a top-hinged one-way flapper valve that is responsive to the patient’s inspiratory effort, and a reservoir bag that captures aerosolized medication during exhalation.

Please Register or Login

You must be logged in to access exclusive content within our clinical resources.

Register Log-in